Loading clinical trials...
Loading clinical trials...
A Screening Protocol to Assess Adult and Adolescent Individuals With Down Syndrome for Eligibility to Participate in an Upcoming Study to Evaluate the Efficacy, Safety and Tolerability of RG1662 (Study BP27832)
Conditions
Locations
22
United States
Univ of CA San Diego; Neurosciences Comp.Alzheimer's
La Jolla, California, United States
Emory University School of Medicine; Department of Human Genetics & Pediatrics
Decatur, Georgia, United States
Rush University Medical Center
Chicago, Illinois, United States
Johns Hopkins Hospital.
Baltimore, Maryland, United States
Massachusette General Hospital; Medical Genetics
Boston, Massachusetts, United States
Duke Clin Rsch Institute
Durham, North Carolina, United States
Start Date
October 31, 2013
Primary Completion Date
January 31, 2015
Completion Date
January 31, 2015
Last Updated
July 19, 2017
NCT04726241
NCT07234695
NCT07248267
NCT07244133
NCT07101523
NCT06512168
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions